Abstract:e17603 Background: The effect of spatial immunologic variation, especially in T cell infiltration, recognition and expansion, across various tumor foci in the ovary (primary) and distant metastatic foci in the peritoneal cavity and their contribution to the limited response to immune therapy in High-Grade Serous Ovarian Cancer(HGSOC) remains unexplored. We aim to provide a detailed analysis of the landscape of heterogeneity of infiltrating T cells in primary and metastatic lesions and their differential characteristics in HGSOC. Methods: We performed multi-site sampling and simultaneous RNA sequencing (RNA-seq), whole-genome sequencing (WGS) and bulk T cell receptor (TCR) sequencing as well as single cell RNA sequencing (scRNA-seq) and paired TCR sequencing (scTCR-seq) in 9 patients (48 sites, including 19 ovarian, 11 omental, 18 other metastasis lesions) with untreated primary HGSOC. Validation by IHC, flow cytometry, another scRNA-seq data from 7 patients (32 sites, including 9 ovarian, 6 omental, 6 ascites and 11 other metastasis lesions) and spatial transcriptomics. Results: CD8 exhausted clusters that are enriched in ovarian tumors exhibited high exhaustion, tumor-specific score and low bystander score, whereas CD8 transition and NK-like clusters that are enriched in omental tumors exhibited the opposite characteristics, which was confirmed by flow cytometry. Of note, the exhausted CD8 + T cells exhibited GZMB, PRF1, FASLG and IFNG effector genes despite the expression of exhaustion markers, developing from an early differentiation state with high proliferative capacity and the process preferentially occurs in primary ovarian sites. Besides, T cells corresponding to the selected TCRs that had the same distribution as neoantigens were enriched in ovarian lesions, while the virus-specific TCR preferentially enriched in omentum samples. The association of TMB, HRD score, and COSMIC mutational signatures with antigen-engaged T cell subsets was not observed at the site level within individual patients. STARTRAC-migration analysis showed that T cell clusters in blood or other sites migrating to ovarian was extremely low or vice versa. The expression of MHC-I processing and presentation genes and MHC-I protein were higher in omental lesions, along with T cells were preferentially located in tumor region of ovarian tumors. Conclusions: We identify two different immune patterns in ovarian cancer: 1) ovarian lesions with low infiltration of mainly dysfunctional T cells and immunosuppressive Treg cells. These exhausted CD8 T cells with cytotoxic function are clonal expanded; 2) omental lesions infiltrated with non-tumor-specific bystander cells. Decreased major histocompatibility complex (MHC)-I antigen presentation ability and failure of T cell infiltration into omental tumors may contribute to lack of tumor-specific T cells in omental metastasis.

Distribution and Functions of Γδ T Cells Infiltrated in the Ovarian Cancer Microenvironment

Ovarian Carcinoma Cell Supernatants Inhibit Proliferation and IL-2R Expression of CD8~+ T Cell

Circulating CD4+ Treg, CD8+ Treg, and CD3+ Γδ T Cell Subpopulations in Ovarian Cancer.

Implication of IL-17 Producing Ɑβt and Γδt Cells in Patients with Ovarian Cancer.

Ovarian Carcinoma Cells Inhibit T Cell Proliferation: Suppression of IL-2 Receptor Β and Γ Expression and Their JAK-STAT Signaling Pathway

Proportion of CD4 CD25 Regulatory T Cell is Increased in the Patients with Ovarian Carcinoma

Ovarian carcinoma cells inhibit ζ chain expression and the secretion of Tc1/Tc2 type cytokines in CD8 + T cells

[Ovarian carcinoma cell inhibits T cell JAK-STAT signal transduction pathway, an experimental study].

Implication Of Il-17 Producing Alpha Beta T And Gamma Delta T Cells In Patients With Ovarian Cancer

Ovarian caremoma cell supernatants inhibit proliferation and IL-2R expression of CD8+ T cell

Recent advances in understanding the immune microenvironment in ovarian cancer

The expression and clinical significance of cytokines Th1, Th2, and Th17 in ovarian cancer

The Immune Subtypes and Landscape of Advanced-Stage Ovarian Cancer

The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer

Research Progress of γδT Cells in Tumor Immunotherapy

Establishing Molecular Subgroups of CD8+ T Cell-Associated Genes in the Ovarian Cancer Tumour Microenvironment and Predicting the Immunotherapy Response

Exploration of the Underlying Biological Differences and Targets in Ovarian Cancer Patients with Diverse Immunotherapy Response

CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation

Immune-Related Genes’ Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer

Multi-omics analysis reveals spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer.

Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer